Literature DB >> 15070693

Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines.

Lorenzo Cosmi1, Francesco Liotta, Roberta Angeli, Benedetta Mazzinghi, Veronica Santarlasci, Roberto Manetti, Laura Lasagni, Vittorio Vanini, Paola Romagnani, Enrico Maggi, Francesco Annunziato, Sergio Romagnani.   

Abstract

T-cell clones generated from both CD4+CD25+ and CD8+CD25+ human thymocytes were assessed for their ability to suppress the proliferative response to allogeneic stimulation of type 1 T-helper (Th1) or type 2 T-helper (Th2) clones derived from autologous CD4+CD25- thymocytes. Both CD4+ and CD8+ T-regulatory (Treg) cells completely suppressed the proliferation of Th1 clones but exhibited significantly lower suppressive activity on the proliferation of Th2 clones. The partial suppressive effect on Th2 cells was further reduced by the addition in culture of interleukin-4 (IL-4), whereas it was increased in the presence of an anti-IL-4 monoclonal antibody (mAb). The suppressive activity on Th2 clones was also completely inhibited by the addition of IL-7, IL-9, and IL-15 but not of IL-2, whereas the suppressive effect on Th1 clones was only reverted by the addition of IL-15. Of note, Th2 clones expressed significantly higher amounts of mRNA for IL-4 receptor (IL-4R) and IL-9R alpha chains than Th1 clones, whereas the expression of mRNA for IL-2R, IL-7R, and IL-15R alpha chains was comparable. Taken together, these findings demonstrate that Th2 cells have a lower susceptibility than Th1 cells to the suppressive activity of human CD25+ regulatory thymocytes, because they are able to produce, and to respond to, growth factors distinct from IL-2, such as IL-4 and IL-9.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15070693     DOI: 10.1182/blood-2003-09-3302

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

1.  IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma.

Authors:  Qiaoling Liang; Lei Guo; Shaila Gogate; Zunayet Karim; Arezoo Hanifi; Donald Y Leung; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

2.  The influence of regulatory T cells and diurnal hormone rhythms on T helper cell activity.

Authors:  Thomas Bollinger; Annalena Bollinger; Julius Naujoks; Tanja Lange; Werner Solbach
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

3.  TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs.

Authors:  Brygida Bisikirska; John Colgan; Jeremy Luban; Jeffrey A Bluestone; Kevan C Herold
Journal:  J Clin Invest       Date:  2005-09-15       Impact factor: 14.808

4.  CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs.

Authors:  Jenny Mjösberg; Göran Berg; Jan Ernerudh; Christina Ekerfelt
Journal:  Immunology       Date:  2007-01-11       Impact factor: 7.397

5.  Effect of CD4(+)CD25(+) regulatory T cells in the development of anterior chamber-associated immune deviation.

Authors:  Shu-Xing Ji; Xiao-Lei Yin; Pei-Zeng Yang
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

6.  Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model.

Authors:  Ana Claudia Zenclussen; Katrin Gerlof; Maria Laura Zenclussen; André Sollwedel; Annarosa Zambon Bertoja; Thomas Ritter; Katja Kotsch; Joachim Leber; Hans-Dieter Volk
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

8.  IL-9 as a mediator of Th17-driven inflammatory disease.

Authors:  Elizabeth C Nowak; Casey T Weaver; Henrietta Turner; Sakhina Begum-Haque; Burkhard Becher; Bettina Schreiner; Anthony J Coyle; Lloyd H Kasper; Randolph J Noelle
Journal:  J Exp Med       Date:  2009-07-13       Impact factor: 14.307

9.  Allergic conjunctivitis renders CD4(+) T cells resistant to t regulatory cells and exacerbates corneal allograft rejection.

Authors:  N J Reyes; P W Chen; J Y Niederkorn
Journal:  Am J Transplant       Date:  2013-03-13       Impact factor: 8.086

Review 10.  The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

Authors:  Sergio Romagnani
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.